Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: J Matern Fetal Neonatal Med. 2022 Jun 5;35(25):9991–10000. doi: 10.1080/14767058.2022.2081803

Table 2.

Adverse outcomes associated with maternal congenital heart disease

Incidence of outcomes
CHD present CHD absent
Adverse outcomes n, % n, %
 Severe maternal morbidity excluding transfusion 1,835 (3.5%) 499,315 (0.7%)
 Cardiac severe maternal morbidity 820 (1.6%) 152,964 (0.2%)
 Placental abruption 900 (1.7%) 971,841 (1.3%)
 Preterm delivery 4,902 (9.5%) 4,811,147 (6.6%)
 Preeclampsia and gestational hypertension 5,264 (10.2%) 5,563,433 (7.6%)
 Cesarean delivery 19,793 (38.2%) 22,545,517 (30.9%)
 Postpartum hemorrhage 2,465 (4.8%) 2,180,032 (3.0%)
 Transfusion 1,062 (2.1%) 637,974 (0.9%)
 Stillbirth 519 (1.0%) 513,280 (0.7%)
Unadjusted models
Adverse outcomes RR (95% CI) RR (95% CI)
 Severe maternal morbidity excluding transfusion 5.18 (4.95, 5.42) 1.0 (reference)
 Cardiac severe maternal morbidity 7.56 (7.05, 8.09) 1.0 (reference)
 Placental abruption 1.31 (1.22, 1.39) 1.0 (reference)
 Preterm delivery 1.44 (1.40, 1.48) 1.0 (reference)
 Preeclampsia and gestational hypertension 1.33 (1.30, 1.37) 1.0 (reference)
 Cesarean delivery 1.24 (1.22, 1.25) 1.0 (reference)
 Postpartum hemorrhage 1.59 (1.53, 1.66) 1.0 (reference
 Transfusion 2.35 (2.21, 2.49) 1.0 (reference)
 Stillbirth 1.42 (1.31, 1.55) 1.0 (reference)
Adjusted models
Adverse outcomes aRR (95% CI) aRR (95% CI)
 Severe maternal morbidity excluding transfusion 4.97 (4.75, 5.20) 1.0 (reference)
 Cardiac severe maternal morbidity 7.65 (7.14, 8.19) 1.0 (reference)
 Placental abruption 1.30 (1.21, 1.38) 1.0 (reference)
 Preterm delivery 1.47 (1.43, 1.51) 1.0 (reference)
 Preeclampsia and gestational hypertension 1.26 (1.22, 1.29) 1.0 (reference)
 Cesarean delivery 1.20 (1.18, 1.22) 1.0 (reference)
 Postpartum hemorrhage 1.56 (1.50, 1.62) 1.0 (reference)
 Transfusion 2.28 (2.14, 2.42) 1.0 (reference)
 Stillbirth 1.41 (1.30, 1.54) 1.0 (reference)

Estimates in the table demonstrate risk in the presence compared to the absence of maternal congenital heart disease. The adjusted models include all the demographic, obstetric, and medical factors in Table 1 including year of delivery, maternal race, maternal age, payer, ZIP code income quartile, pre-gestational diabetes, chronic hypertension, singleton versus multiple gestation, and obesity.